Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC

Kobe Minimally Invasive Cancer Center · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
non-small-cell-lung-cancerpembrolizumab
locally advanced non-small cell lung cancer, pembrolizumab, platinum doublets, non-small cell lung cancer, without radiation, locally advanced, pd-l1 ≥50%, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 813003
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.